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Background: Repetitive transcranial magnetic stimulation (rTMS) has been studied
as a treatment option for chronic tinnitus for almost 10 years now. Although most
of these studies have demonstrated beneficial effects, treatment results show high
interindividual variability and yet, little is known about predictors for treatment response.
Methods: Data from 538 patients with chronic tinnitus were analyzed. Patients received
either low-frequency rTMS over the left temporal cortex (n = 345, 1Hz, 110% motor
threshold, 2000 stimuli/day) or combined temporal and frontal stimulation (n = 193, 110%
motor threshold, 2000 stimuli at 20Hz over left dorsolateral prefrontal cortex plus 2000
stimuli at 1Hz over temporal cortex). Numerous demographic, clinical, and audiological
variables as well as different tinnitus characteristics were analyzed as potential predictors
for treatment outcome, which was defined as change in the tinnitus questionnaire (TQ)
score. Results: Both stimulation protocols resulted in a significant decrease of TQ scores.
Effect sizes were small, however. In the group receiving combined treatment, patients
with comorbid temporomandibular complaints benefited more from rTMS than patients
without those complaints. In addition, patients with higher TQ scores at baseline had more
pronounced TQ reductions than patients with low TQ baseline scores. Also, patients who
had already improved from screening to baseline benefited less than patients without
initial improvement. Conclusions: The results from this large sample demonstrate that
rTMS shows only small but clinically significant effects in the treatment of chronic tinnitus.
There are no good demographic or clinical predictors for treatment outcome.
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INTRODUCTION
Subjective tinnitus is defined as a perception of sound that is not
linked to an internal or external sound source. It is considered a
common symptom affecting about 10–15% of adults (Hoffman
and Reed, 2004) some of which are considerably impaired in
their everyday lives. Chronic tinnitus is often accompanied by
hearing loss, comorbid depression, sleeping problems, anxiety,
and psychological stress (Halford and Anderson, 1991; Langguth,
2011). Tinnitus sufferers are considered a heterogeneous group
of patients which might be divisible into several subgroups with
different underlying pathophysiologies and thus benefiting from
different treatment options (Landgrebe et al., 2010). Various
criteria for subtyping have been proposed based both on clin-
ical experience (Levine et al., 2008; Lindblad et al., 2011) and
on empirical data (Tyler et al., 2008; Vielsmeier et al., 2011).
However, it still remains a major challenge to identify useful
criteria for identifying clinically relevant subtypes.
Studies using positron emission tomography (PET) and func-
tional magnetic resonance imaging (fMRI) indicate altered neu-
ronal activity in the central auditory system in patients with
chronic tinnitus (for a review see Lanting et al., 2009). These
alterations supposedly result from reorganization processes in the
central nervous system that occurs as a consequence of abnormal
auditory input (Eggermont, 2005). Furthermore, altered activity
has also been found in non-auditory areas such as the frontal cor-
tex or the amygdalohippocampal area (for a review see Adjamian
et al., 2009). As repetitive transcranial magnetic stimulation
(rTMS) is able to modify cortical excitability, it has been intro-
duced as a new treatment option for chronic tinnitus. rTMS is a
non-invasive technique applying magnetic fields for the purpose
of modulating neural activity. These magnetic fields are produced
by a pulsed electrical current flowing through a coil which is
placed on the scalp. The magnetic fields pass through the skull
and induce an electrical current in the underlying cortical neu-
rons. If applied repetitively, long lasting changes in the excitability
of directly stimulated cortical neurons as well as in function-
ally connected areas can be obtained. It depends on stimulation
parameters if those changes act in an inhibitory or excitatory
way (Ridding and Rothwell, 2007). Studies on the motor cor-
tex revealed that low-frequency rTMS (≤1Hz) inhibits neural
activity whereas high-frequency rTMS (≥5Hz) increases cortical
excitability (Fitzgerald et al., 2006). As rTMS turned out to be
effective in other hyperexcitability disorders like auditory halluci-
nations (Hoffman and Cavus, 2002), several studies investigated
the effectiveness of low-frequency rTMS over auditory cortical
areas in patients with chronic tinnitus (Kleinjung et al., 2005;
Frontiers in Systems Neuroscience www.frontiersin.org February 2012 | Volume 6 | Article 11 | 1
SYSTEMS NEUROSCIENCE
Lehner et al. rTMS response in chronic tinnitus
Plewnia et al., 2007b; Smith et al., 2007; Khedr et al., 2008).
Recently, the frontal cortex was examined as an additional target
area as well (Kleinjung et al., 2008; Kreuzer et al., 2011). While
the majority of those studies reported beneficial effects of rTMS
on tinnitus severity, treatment outcomes varied highly across
patients (Langguth et al., 2008a; Frank et al., 2010; Plewnia, 2011).
It would, therefore, be of high clinical relevance to find out, which
patient characteristics are predictive for treatment outcome as it
would then be possible to offer rTMSmore systematically to those
patients who will most likely show positive response. Moreover,
the mechanisms by which rTMS exerts beneficial effects on tin-
nitus are still incompletely understood (Langguth et al., 2008a;
Mennemeier et al., 2011). More detailed knowledge about clini-
cal and demographic characteristics of treatment responders may
also shed light on the neurobiological mechanisms of rTMS in the
treatment of tinnitus.
Some previous studies which examined the effect of rTMS on
chronic tinnitus already reported an influence of clinical char-
acteristics on treatment outcome. Tinnitus duration was found
to have an effect on treatment response in studies using sin-
gle sessions (De Ridder et al., 2005; Plewnia et al., 2007a) and
repeated sessions of rTMS (Kleinjung et al., 2007; Khedr et al.,
2008, 2010) showing that patients with shorter tinnitus duration
improve more than patients with longer tinnitus duration. Some
studies also indicate that patients with normal hearing develop
better treatment response than patients with hearing loss (Fregni
et al., 2006; Kleinjung et al., 2007) and that patients with left or
bilateral tinnitus benefit more from left-sided rTMS than patients
with right-sided tinnitus (Frank et al., 2010). Still, these results
are debatable as there are just as many studies suggesting that
tinnitus duration (Folmer et al., 2006; Rossi et al., 2007; Burger
et al., 2011) or tinnitus laterality (Kleinjung et al., 2007; Rossi
et al., 2007; Khedr et al., 2008) do not have any influence on
treatment outcome, or that rTMS contralateral to the tinnitus
side is most efficient (Khedr et al., 2010). In addition to these
diverging results, most of the mentioned studies investigated only
small samples and examined only the influence of demographical
data, tinnitus side, and tinnitus duration on treatment outcome.
Although there are studies which have taken additional charac-
teristics into account (Kleinjung et al., 2007; Frank et al., 2010;
Burger et al., 2011), there are many variables left which have
not been considered yet. The aim of the current study is, there-
fore, to identify predictors for treatment outcome, including a
larger amount of clinical and demographic variables as potential
predictors. In order to identify the possible existence of differ-
ent predictors for treatment with temporal and for combined
frontal plus temporal rTMS, both treatment protocols were exam-
ined separately. The analysis has been conducted on pooled data
stored in the database of the tinnitus research initiative (TRI)
(Landgrebe et al., 2010), providing large sample sizes and thus
allowing generalization of results.
MATERIALS AND METHODS
SUBJECTS
Taken as a whole, data from 538 patients with chronic tinni-
tus were analyzed. 345 (248 men, 97 women; mean age 50.14 ±
13.10 years) patients were treated with left temporal rTMS. The
remaining 193 patients (135 men and 58 women, mean age
51.12 ± 11.91 years) received a combined frontal and temporal
treatment. rTMS was either done in the course of different clin-
ical trials (Kleinjung et al., 2005, 2008, 2009b, 2011; Langguth
et al., 2006b, 2008b) or as compassionate use treatment between
2003 and January 2011. As the studies of Kleinjung et al. (2009b,
2011) revealed no enhancing effect of Levodopa or Bupropion
on rTMS outcome, data of those studies were included in the
current analysis. All participants were treated at the Tinnitus
Center at the University of Regensburg, Germany and gave writ-
ten informed consent after comprehensive explanation of the
procedures. Patient data was kept confidential throughout all
analyses, which have been approved by the local ethics committee.
Patients with a history of epilepsy, cardiac pacemakers or other
contraindications to TMS were excluded from treatment.
CLINICAL ASSESSMENT AND OUTCOME MEASUREMENT
Demographical and clinical characteristics were assessed by using
the Tinnitus Sample Case History Questionnaire (Langguth et al.,
2007a). Characteristics of both patient groups are given in
Table 1. As not every variable was available for every patient, the
table provides sample sizes for each variable separately. For cal-
culation of the hearing level [dB HL], all thresholds measured in
pure-tone audiogram from 125Hz to 8 kHz and from both sides
were averaged. If hearing was too bad to assess a threshold, the
value was set to 110 dB. Tinnitus pitch was defined as the geomet-
ric mean of the lower and upper bound frequency [Hz] measured
during the audiological examination.
Assessment of treatment effects was performed using
standardized procedures as established in the TRI database
(Landgrebe et al., 2010). This follows the consensus for patient
assessment and outcome measurement approved by tinnitus
experts from many countries during an international tinnitus
conference in 2006 (Langguth et al., 2007a).
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION
Patients were treated with rTMS on 10 consecutive working days,
receiving one of two possible treatment protocols. Either low-
frequency rTMS was applied over the left temporal cortex (1Hz,
2000 stimuli/day) or a combined stimulation over the left tempo-
ral (1Hz, 2000 stimuli/day) and left dorsolateral prefrontal cortex
(20Hz, 40 trains with 50 stimuli and an intertrain interval of
25 s) was performed. As both protocols differ substantially with
respect to stimulation sites and number of stimuli, data from
the 1Hz and 20 + 1Hz treatment were analyzed separately. For
both protocols, stimulation intensity was set at 110% of the indi-
vidual resting motor threshold but never higher than 60% of
maximal stimulator output. Motor threshold was defined as the
minimal intensity sufficient to produce motor-evoked potentials
of at least 50μV in the left thenar muscle in five out of 10 tri-
als. Localization of the stimulated areas was either done with a
neuronavigational system or by using a standard procedure based
on the 10–20 system (Langguth et al., 2006b). As there is no
evidence for neuronavigation being superior to the 10–20 sys-
tem (Langguth et al., 2010), data were pooled without taking the
localization method into account. For all patients, a Medtronic
system with a figure-of-eight coil (90mm outer diameter; Alpine
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Table 1 | Demographical data and clinical characteristics for both treatment groups.
n Temporal rTMS n Frontal + Temporal rTMS
Gender 345 M (72%)
F (28%)
193 M (70%)
F (30%)
Age (years) 345 50.14 ± 13.10 193 51.12 ± 11.91
Handedness 334 Right (86%)
Left (6%)
Both Sides (8%)
186 Right (79%)
Left (9%)
Both Sides (12%)
Hearingthreshold (dB) 224 20.19 ± 12.68 157 21.26 ± 13.98
Hearing loss (left/right) 205 0–20dB (21%/23%)
21–60dB (62%/56%)
>60dB (17%/21%)
146/148 0–20dB (23%/24%)
21–60dB (57%/52%)
>60dB (20%/24%)
BDI 221 9.88 ± 7.98 181 13.67 ± 8.65
Motor threshold 345 43.14 ± 8.50 192 42.52 ± 8.11
TQ baseline 345 38.49 ± 17.60 193 45.25 ± 17.84
TQ difference (baseline – screening) 285 −1.99 ± 9.48 166 −1.43 ± 9.58
Tinnitus laterality 335 Right (14%)
Left (18%)
Both ears worse left (16%)
Both ears worse right (16%)
Both ears equally (29%)
Inside the head (7%)
188 Right (11%)
Left (15%)
Both ears worse left (21%)
Both ears worse right (18%)
Both ears equally (24%)
Inside the head (11%)
Tinnitus duration (years) 328 7.75 ± 7.43 181 7.62 ± 8.73
Tinnitus pitch 104 6780.62± 3662.23 97 6712.60± 3484.62
Tinnitus pitch (patient rating) 205 Very high frequency (22%)
High frequency (60%)
Medium frequency (16%)
Low frequency (2%)
176 Very high frequency (29%)
High frequency (57%)
Medium frequency (13%)
Low frequency (1%)
Tinnitus quality 202 Tone (67%)
Noise (8%)
Crickets (19%)
Other (6%)
173 Tone (57%)
Noise (14%)
Crickets (19%)
Other (10%)
Event-related to tinnitus onset 206 Loud blast of sound (4%)
Whiplash (0%)
Change in hearing (14%)
Stress (19%)
Head trauma (0%)
Others (37%)
More than one event (26%)
163 Loud blast of sound (5%)
Whiplash (2%)
Change in hearing (6%)
Stress (22%)
Head trauma (1%)
Others (33%)
More than one event (31%)
Pulsating tinnitus 181 No (84%)
Yes with heart beat (10%)
Yes, different from heart beat (6%)
166 No (79%)
Yes with heart beat (9%)
Yes, different from heart beat (12%)
Tinnitus manifestation 235 Intermittent (11%)
Constant (89%)
171 Intermittent (9%)
Constant (91%)
Varying Tinnitus loudness 189 No (40%)
Yes (60%)
167 No (32%)
Yes (68%)
Tinnitus reduced by music or sounds 269 No (24%)
Yes (65%)
I don’t know (11%)
170 No (24%)
Yes (62%)
I don’t know (14%)
Loud noise makes tinnitus worse 205 No (24%)
Yes (60%)
I don’t know (16%)
169 No (19%)
Yes (59%)
I don’t know (22%)
Neck movement affects tinnitus 185 No (67%)
Yes (33%)
169 No (63%)
Yes (37%)
Stress influences tinnitus 187 No (29%)
Yes (71%)
162 No (72%)
Yes (28%)
(Continued)
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Table 1 | (Continued)
n Temporal rTMS n Frontal + Temporal rTMS
Suffer from headache 188 No (68%)
Yes (32%)
168 No (53%)
Yes (47%)
Suffer from vertigo 326 No (71%)
Yes (29%)
181 No (63%)
Yes (37%)
Temporomandibular complaints 287 No (80%)
Yes (20%)
171 No (75%)
Yes (25%)
Suffer from neck pain 310 No (50%)
Yes (50%)
174 No (37%)
Yes (63%)
Biomed, Minneapolis, MN, USA) was used with the handle of the
coil pointing upwards.
DATA ANALYSIS
Statistical analysis was performed with PASW statistics 18 (SPSS
Inc, Chicago, IL). All analyses were conducted separately for
the 1Hz and the 20 + 1Hz group. The data analysis was based
on data of the TRI Database. Data management was con-
ducted according to the Data Handling Plan (TRI-DHP V07,
09.05.2011). Data analysis for the combined frontal and tempo-
ral group was conducted according to the Standard Operating
Procedure (TRI-SA V01, 09.05.2011) thereby following a study-
specific Statistical Analysis Plan (SAP) that was written according
to the SAP template (TRI-SAP 005, 26.10.2011). Data from the
temporal group were analyzed analogously. All documents are
to be found under http://database.tinnitusresearch.org/. Tinnitus
severity was assessed at four time points using the German
Version of the tinnitus questionnaire (TQ; Goebel and Hiller,
1994): before rTMS treatment (“screening,” “baseline”), after the
last treatment session (“day 12”) and after a follow-up period
of three months (“day 90”). Screening data were collected when
patients visited the Tinnitus Center for the first time (gener-
ally during tinnitus consultation hours), whereas baseline data
were collected immediately before treatment started. To test for
changes in tinnitus severity from baseline to day 12 as well as from
baseline to day 90, paired t-tests were used. Responder rates were
calculated with responders defined as patients having improved
by five points or more in the TQ score (Kleinjung et al., 2007;
Frank et al., 2010). To identify predictors for treatment outcome,
all variables listed in Table 1 were included as potential predic-
tors. Besides demographical data and hearing loss, several tinnitus
characteristics and selected somatic disorders like headache or
neck pain were analyzed. Differences of TQ scores between base-
line and day 12 as well as between baseline and day 90 were used as
variables for treatment outcome. As the baseline score was used as
subtrahend, negative values describe an improvement in tinnitus
severity whereas positive values describe a worsening of tinnitus.
In a first step, correlations between the dependent variables
and all predictors were conducted. Dependent on levels of mea-
surement, product-moment correlations, point biserial correla-
tions, or eta were used. ε2 is a measure of explained variance and
thus indicates, howmuch of the dependent variable’s variance can
be explained by the independent variable. In a second step, those
predictors showing significant correlations with the independent
variables were analyzed in a multiple regression analysis. All sta-
tistical tests were two-tailed, unadjusted formultiple comparisons
and a value of p < 0.05 was used to determine statistical sig-
nificance. In correlation analyses, pair-wise deletion of missing
values was applied. In regression analysis, missing values were
deleted list-wisely. Data in the text are given as mean ± standard
deviation.
RESULTS
rTMS was well tolerated, no serious adverse effects were observed.
Paired t-tests revealed a significant change of tinnitus severity at
day 12 for both temporal [T(332) = 6.54, p < 0.001, d = 0.36]
and combined treatment [T(180) = 3.61, p < 0.001, d = 0.27].
At day 90, tinnitus severity was still significantly decreased in
patients receiving combined stimulation [T(154) = 2.35, p =
0.012, d = 0.20] whereas in patients receiving temporal stimu-
lation the effect did not reach significance any more [T(291) =
1.88, p = 0.061, d = 0.11] (see Figure 1). Both groups showed
similar responder rates which were stable over time: among the
patients receiving temporal stimulation, 37% improved by five
points or more on the TQ score at day 12 and 36% at day 90. In
the group treated with temporal plus frontal stimulation, 38% of
patients were classified as responders at day 12 and 38% at day 90.
Only some of the predictors were significantly correlated with
treatment outcome and these correlations were, though statis-
tically significant, only weak to moderate ones (see Table 2).
In both groups, TQ difference from screening to baseline and
treatment outcome on both day 12 and day 90 were negatively
correlated. This means that those patients in which the TQ score
increased from screening to baseline benefited more from treat-
ment with rTMS than patients with improvement from screening
to baseline. Furthermore, in both treatment groups, the TQ score
on baseline was negatively correlated with treatment outcome on
day 12 and day 90. Accordingly, patients with higher TQ scores
at baseline had more pronounced TQ reductions after rTMS than
patients with low TQ baseline scores. A similar result appeared
for the BDI score on baseline: the higher the score on baseline,
the more decrease in tinnitus severity was observed. However, this
latter result is only true for treatment outcome on day 12 and only
in the group receiving temporal stimulation.
In the group receiving combined treatment more investi-
gated variables had a significant effect on treatment outcome.
First, tinnitus manifestation (constant vs. intermittent) was cor-
related with treatment outcome on day 12 with patients with
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FIGURE 1 | Line chart including mean values and standard errors of TQ scores before (“screen,” “baseline”) and after (“day 12,” “day 90”) rTMS
treatment for both treatment groups.
Table 2 | Correlations between treatment outcome and predictors for both treatment groups.
Temporal rTMS Frontal + Temporal rTMS
Treatment outcome Treatment outcome Treatment outcome Treatment outcome
day 12 day 90 day 12 day 90
PRODUCT MOMENT CORRELATION r
TQ difference (baseline – screen) −0.187** −0.229** −0.231** −0.183*
TQ baseline −0.313** −0.230** −0.189* −0.170*
Age (years) 0.017 −0.037 −0.025 0.001
Motor threshold 0.005 −0.035 0.010 0.014
BDI −0.240** −0.127 −0.067 −0.060
Hearing threshold −0.034 0.007 0.009 0.086
Tinnitus duration (years) 0.043 0.032 −0.113 0.102
Tinnitus pitch −0.080 −0.146 0.088 −0.013
POINT BISERIAL CORRELATION r
Gender −0.051 −0.053 −0.131 0.002
Tinnitus manifestation 0.030 0.070 −0.169* −0.067
Varying tinnitus loudness −0.059 0.039 0.010 0.010
Neck movement affects tinnitus 0.028 −0.025 0.036 0.036
Stress influences tinnitus 0.064 0.006 0.147 0.025
Suffer from headache 0.032 0.087 0.085 −0.015
Suffer from vertigo −0.048 −0.067 0.001 0.117
Temporomandibular complaints −0.042 −0.032 −0.184* −0.187*
Suffer from neck pain −0.099 −0.064 −0.045 0.014
ε2
Handedness 0.003 0.002 0.004 0.008
Hearing loss (left/right) 0.000/0.005 0.001/0.011 0.006/0.010 0.010/0.006
Tinnitus laterality 0.006 0.017 0.025 0.013
Tinnitus pitch (patient rating) 0.058 0.026 0.020 0.018
Tinnitus quality 0.017 0.025 0.026 0.005
Event-related to tinnitus onset 0.047 0.011 0.049 0.034
Pulsating tinnitus 0.012 0.039 0.010 0.013
Tinnitus reduced by music or sounds 0.015 0.010 0.003 0.023
Loud noise makes tinnitus worse 0.017 0.014 0.007 0.021
∗α < 0.05.
∗∗α < 0.001.
constant tinnitus benefiting more from rTMS than patients with
intermittent tinnitus. This effect could not be depicted for data
on day 90 though. Finally, a significant influence of comor-
bid temporomandibular complaints on treatment outcome was
found. Patients suffering from temporomandibular complaints
experienced more benefit from rTMS than patients without tem-
poromandibular complaints.
As can be seen in Table 2, ε2 was quite low with 5.8%
being the highest value. Those 5.8% are explained by “tinnitus
pitch.” However, the category being responsible for this minimal
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correlation is “low pitch.” Since the sample sizes of the “low pitch”
groups are very small (see Table 1) the result is assumed to be
an idiosyncratic effect of the small samples. The same is true for
the variable “event related to onset of tinnitus.” All remaining
correlations did not reach statistical significance.
Regression analysis was conducted separately for both treat-
ment groups and time points. Only variables significantly cor-
related with treatment outcome were included in the analyses.
Consequently, each analysis contained a different number of
independent variables. In all analyses, the TQ difference from
screening to baseline proved to be a significant predictor for
treatment outcome. For the group receiving temporal stimula-
tion, TQ score at baseline appeared as an additional predictor for
treatment outcome on day 90 but did not reach statistical sig-
nificance in the remaining analyses (see Table 3). BDI score on
baseline, which was only included in one regression model (tem-
poral stimulation, day 12), was detected as a significant predictor
in this model. Furthermore, in the group receiving combined
stimulation, temporomandibular complaints predicted treatment
outcome on both day 12 and day 90, whereas tinnitus manifes-
tation (intermittent vs. continuous) did not serve as a relevant
predictor for treatment outcome any more. The coefficients for
determination in the different models range from 0.065 to 0.111.
DISCUSSION
The current results from a large sample indicate that rTMS sig-
nificantly decreases tinnitus severity in tinnitus patients. Owing
to the large sample size, the rather small change in TQ scores
(between 4–10%) reaches statistical significance while the effect
sizes are only small to moderate. Of course, the question arises
if this small decrease in tinnitus severity can be considered
not only statistically significant but also clinically relevant. It
has to be taken into account that—apart from behavioral ther-
apy (Hesser et al., 2011b)—there are no therapeutic tools for
chronic tinnitus available for which the evidence of efficacy has
already been clearly provided by metaanalyses. Facing this lack
of highly effective therapeutic alternatives, the observed improve-
ment of at least 5 points in the TQ score in 36–38% of all
treated patients is a remarkable result, which represents—at least
for these responders—a clinically relevant tinnitus reduction.
Although the mean TQ score reduction and the effect size of
rTMS are small, it brings improvement to patients who would
otherwise have no real therapeutic alternatives. The small effect
sizes should, therefore, not lead to the conclusion that rTMS is not
efficient enough to be examined in future studies. The small effect
sizes rather point to the potential of rTMS, but also to the need for
future studies to further improve treatment outcome by apply-
ing rTMS over new stimulation sites or by changing stimulation
frequencies (Kleinjung and Langguth, 2009a).
Regarding the stimulation protocol, both temporal and com-
bined stimulation resulted in a decrease of tinnitus severity on
day 12, but significant improvement on day 90 was only observ-
able in the patients receiving combined stimulation. This result is
consistent with the finding of Kleinjung et al. (2008) suggesting
that combined stimulation has longer lasting effects on chronic
tinnitus than temporal stimulation only.
Regarding predictors for treatment outcome, some of the char-
acteristics analyzed were significantly correlated with treatment
outcome. These correlations have to be interpreted with caution
however, as they are only weak to moderate ones. Two parameters
were significantly correlated to treatment outcome in both treat-
ment groups: the change of tinnitus severity from screening to
baseline and the tinnitus severity at baseline. Furthermore, in the
group receiving combined stimulation, patients with comorbid
temporomandibular complaints benefited more from rTMS than
patients without temporomandibular complaints. Additionally,
depressivity at baseline (assessed by the BDI score) was signifi-
cantly correlated with treatment outcome on day 12 in patients
receiving temporal stimulation. In the group receiving com-
bined stimulation, patients with constant tinnitus showed more
improvement on day 12 compared to patients with intermittent
tinnitus. However, those latter results were not found for treat-
ment outcome on day 90 indicating that neither depressivity nor
tinnitus manifestation exert considerable influence on long-term
effects of rTMS. This assumption is supported by regression anal-
ysis which reveals that only two of the parameters mentioned
remain as significant predictors of treatment outcome: change of
tinnitus severity from screening to baseline and suffering from
temporomandibular disorder (for patients receiving combined
treatment only).
In detail, the changing TQ score from screening to baseline is
the strongest predictor for treatment outcome, reaching statistical
Table 3 | Results of multiple regression analyses for both treatment groups: standardized regression coefficients (β).
Temporal rTMS Frontal + Temporal rTMS
Treatment outcome Treatment outcome Treatment outcome Treatment outcome
day 12 day 90 day 12 day 90
Tinnitus manifestation − − −0.141 −
Temporomandibular complaints − − −0.189* −0.190*
TQ difference (baseline−screen) −0.169* −0.176** −0.244** −0.215*
TQ baseline −0.122 −0.159* −0.078 −0.068
BDI −0.184* − − −
corr. R2 0.111 0.067 0.110 0.065
∗α < 0.05.
∗∗α < 0.001.
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significance for both treatment groups and both day 12 and
day 90. This robust finding is remarkable since the time inter-
val between screening and baseline was not standardized and
varied across patients. Patients worsening from screening to base-
line benefited more from rTMS than patients who had improved
between screening and the beginning of rTMS treatment. A
similar relationship has been observed in a recent rTMS study
(Kreuzer et al., 2011). Other earlier rTMS studies did not ana-
lyze whether changes of tinnitus severity before treatment start
has an influence on treatment effects. Several explanations can
be provided for this relative robust finding of an influence of the
pre-treatment changes on treatment effects. The change between
screening and baseline may reflect anticipation effects which are
known from waiting list control groups (Hesser et al., 2011a).
Thus, the inverse relationship between score changes before treat-
ment and score changes during treatment could be explained by
anticipation alone. Those patients, who improved already before
treatment because of anticipation show less further improvement
during treatment, because they have to catch up the anticipation
effect first, whereas those who increase with their score between
screening and baseline, have a more pronounced reduction dur-
ing treatment since they realized, that their worries about the
coming rTMS treatment, which might have caused the increase
of the scores, were unwarranted.
From a more neurobiological approach the observed effect can
be explained by the known dependency of rTMS effects on the
history of synaptic activity of the stimulated brain area.
It has been shown that priming of cortical excitability with
transcranial direct current stimulation modulates the effects of
rTMS both over the motor cortex (Lang et al., 2004; Siebner
et al., 2004) and to a lesser extent over the visual cortex (Lang
et al., 2007). Based on these findings it has been suggested that
effects of rTMS depend critically on the history of neuronal activ-
ity. Clinical effects can then be interpreted as normalization of
pathologically increased activity (Siebner et al., 2004) provid-
ing an explanation why effects from healthy controls cannot be
extrapolated on effects on patients with pathologically enhanced
activity.
Thus, if we assume that the change in the tinnitus score before
begin of TMS is reflected by changes of neuronal excitability in
the stimulated area (van der Loo et al., 2009), then the observed
inverse relation between changes before and during treatment
could be explained as an rTMS induced enhancement of home-
ostatic mechanisms. Further studies should use neuroimaging
methods for assessing neuronal activity at different time points
before, during and after rTMS to further identify to which extent
changes of neuronal activity before treatment beginning influ-
ence treatment effects. Moreover, it is strongly recommended
that future clinical trials include multiple baseline assessments
to identify the potential influence of pre-treatment dynamics on
treatment effects and to rule out individual tinnitus oscillation
patterns possibly interfering with treatment effects.
Although tinnitus severity at baseline was no significant pre-
dictor in the regression analysis, it correlates significantly with
treatment outcome—a result that is consistent with previous
studies reporting a negative relation between tinnitus severity
at baseline and treatment outcome as well (Frank et al., 2010;
Burger et al., 2011). Patients with a higher TQ score on base-
line showed stronger reductions in TQ scores than patients who
had low scores at the beginning. As Frank et al. (2010) already
conjectured, this might be partly due to the fact that treatment
outcome was defined as the difference between the TQ score on
baseline and day 12/day 90. This approach assumes that a reduc-
tion of five points is of comparable clinical relevance no matter
if this reduction is from a score of 65 to 60 (7.7% improve-
ment) or from 25 to 20 (20% improvement). This is probably
not the case and it remains a matter of debate whether the actual
improvement perceived by the patient is better expressed by the
percentaged change of TQ scores or by the difference of TQ scores
(Zeman et al., 2011). Future studies should try to bring clarity to
this issue.
Apart from tinnitus severity itself, only one additional char-
acteristic had an important influence on treatment outcome: the
presence or absence of temporomandibular complaints. Patients
with temporomandibular complaints benefited significantly more
from combined frontal and temporal rTMS than patients without
these complaints. It has been suggested that in tinnitus patients
with temporomandibular complaints, abnormal somatosensoric
input from the trigeminal nerve may be critically involved in the
pathophysiology of tinnitus (Levine et al., 2008; Vielsmeier et al.,
2011). Moreover in patients with so-called somatic tinnitus treat-
ment interventions aiming at normalizing afferent somatic input
have shown benefit (Bezerra Rocha et al., 2008; Biesinger et al.,
2008).
In addition to its effect on cortical neurons rTMS always exerts
an effect on peripheral nerves and muscles. Peripheral effects of
rTMS have been shown to reduce pain perception (Zunhammer
et al., 2011) and it has also been suggested that the peripheral
effects of rTMS may be involved in tinnitus reduction after sin-
gle sessions of rTMS (Vanneste et al., 2011). Thus, one could
speculate that in patients with comorbid temporomandibular
problems tinnitus might be especially sensitive for modulation of
sensory input resulting in tinnitus reduction via peripheral effects
of rTMS on the temporal muscle.
However, the ability to modulate tinnitus by jaw-, head-, or
neckmovements was not related to treatment success, contradict-
ing the explanation that patients who are especially sensitive to
somatosensoric input benefit more from rTMS.
Beyond that, it is not directly evident why the effect of tem-
poromandibular complaints is only seen in the group of patients
who received combined stimulation whereas those complaints
had no effect on treatment outcome in patients treated with
temporal stimulation only. It seems somewhat implausible that
frontal stimulation is crucial for the improvement in patients
with temporomandibular complaints, since it is muchmore likely
to reach the temporal muscle and the trigeminal nerve through
temporal stimulation. Theoretically, left frontal rTMS might have
had a beneficial effect on temporomandibular complaints, simi-
lar like on experimental pain (Fierro et al., 2010; Brighina et al.,
2011). Unfortunately, current data contain no information about
improvement of temporomandibular complaints after rTMS. It is,
therefore, uncertain if improvement of temporomandibular com-
plaints and tinnitus co-occur or if only tinnitus improves while
temporomandibular complaints remain unchanged.
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Thus, replication of the current exploratory results is needed
to rule out the possibility that the effect of temporomandibular
complaints on treatment outcome is—though being statistically
significant—a random effect only observable in the present sam-
ple of patients.
None of the remaining characteristics (see Table 1) are suit-
able predictors for treatment outcome. Consequently, previous
results indicating that tinnitus duration (Khedr et al., 2008, 2010;
Kleinjung et al., 2007), hearing loss (Fregni et al., 2006; Kleinjung
et al., 2007), or tinnitus laterality (Frank et al., 2010) may predict
treatment outcome are not supported. The current study used
a large sample of patients with chronic tinnitus. It is, therefore,
highly improbable that the failure to identify a clear set of reliable
predictors is due to insufficient statistical power. Consequently,
there are only three possible factors which might have caused
these results: the outcome measures, the predictors or the rela-
tionship between them. This means that the TQ (and the use of
its difference between two time points, respectively) might not be
a suitable outcome measure. Perhaps, a rating scale for tinnitus
loudness, the tinnitus handicap inventory or any other measure
might have given different results. The TQ was used as it is a well-
known standard measure for tinnitus severity. Future research
should analyze however, if the TQ shows enough sensitivity to
change or if another outcome measure should be preferred.
Furthermore, although numerous clinical variables were included
as predictors for treatment outcome, it is possible that we still
missed relevant characteristics. No previous study reported that
rTMS might be particularly effective in patients with temporo-
mandibular complaints—maybe just because those complaints
were not measured. The same could be the case with other vari-
ables we simply did not ask for. This assumption is supported
by the finding that the predictors entered into regression analy-
ses explain only between 6.5% and 11.1% of variability in rTMS
outcome. Another possibility is that clinical characteristics are
less relevant for treatment outcome than neurophysiological or
neuroimaging characteristics. Since the neurobiological mecha-
nisms induced by rTMS are known to depend on the neuronal
activity of the stimulated brain area, neuroimaging and electro-
physiological methods may be better suitable for predicting rTMS
effects (Langguth et al., 2006a, 2007b; Plewnia et al., 2007b). In
this context it may be of relevance that there is only a relatively
weak correlation between clinical characteristics and imaging
data (Schecklmann et al., 2011a). Finally, the possibility cannot
be ignored that there might be no further associations between
predictors and treatment outcome—an interpretation which sug-
gests that in many patients, it might not be rTMS specific effects
which are responsible for treatment response but rather unspe-
cific effects caused by regular physician contact and counseling. It
should not be neglected, however, that several placebo-controlled
studies already controlled for those effects and proved that rTMS
is superior to placebo in the treatment of patients with chronic
tinnitus (Kleinjung et al., 2005; Plewnia et al., 2007b; Rossi et al.,
2007; Marcondes et al., 2010). Another placebo-controlled non-
crossover study with an adequate sample size should try to bring
further clarity to this issue (Landgrebe et al., 2008).
The most important conclusion that can be drawn from our
results is that rTMS shows only small effects in the treatment
of chronic tinnitus. These effects are considered clinically sig-
nificant, however. There are no good demographic or clinical
predictors for treatment outcome. The observed inverse relation-
ship between changes before treatment beginning and during
treatment argues for the use of multiple baseline assessments in
future clinical trials. The finding that patients suffering from tem-
poromandibular complaints benefit more from a treatment with
rTMS than patients without temporomandibular complaints sug-
gests that the effects by which rTMS exerts clinical effects may also
involve the peripheral nervous system. If the clicking sounds pro-
duced during rTMS treatment are additionally taken into account
(Schecklmann et al., 2011b), the influence of rTMS on chronic
tinnitus might be the sum of central, somatosensoric, and audi-
tory stimulation processes. A closer insight into this interplaymay
help to refine the treatment of chronic tinnitus with rTMS.
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